Bromodomain Containing Protein 2
Bromodomain Containing Protein 2 market is segmented by region (country), players, by Type and by ... Read More
Global and United States Liver Failure Therapeutics Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Liver Failure Therapeutics Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Liver Failure Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Liver Failure Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Liver Failure Therapeutics Market Size for the Year 2017-2028
1.3 Liver Failure Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Liver Failure Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Liver Failure Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Liver Failure Therapeutics Market Dynamics
1.4.1 Liver Failure Therapeutics Industry Trends
1.4.2 Liver Failure Therapeutics Market Drivers
1.4.3 Liver Failure Therapeutics Market Challenges
1.4.4 Liver Failure Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Liver Failure Therapeutics by Type
2.1 Liver Failure Therapeutics Market Segment by Type
2.1.1 Ornithine Phenylacetate
2.1.2 MTL-CEBPA
2.1.3 F-573
2.1.4 BL-1220
2.1.5 PP-100
2.1.6 Others
2.2 Global Liver Failure Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Liver Failure Therapeutics Market Size by Type (2017-2028)
2.4 United States Liver Failure Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Liver Failure Therapeutics Market Size by Type (2017-2028)
3 Liver Failure Therapeutics by Application
3.1 Liver Failure Therapeutics Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Liver Failure Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Liver Failure Therapeutics Market Size by Application (2017-2028)
3.4 United States Liver Failure Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Liver Failure Therapeutics Market Size by Application (2017-2028)
4 Global Liver Failure Therapeutics Competitor Landscape by Company
4.1 Global Liver Failure Therapeutics Market Size by Company
4.1.1 Top Global Liver Failure Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Liver Failure Therapeutics Revenue by Player (2017-2022)
4.2 Global Liver Failure Therapeutics Concentration Ratio (CR)
4.2.1 Liver Failure Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Liver Failure Therapeutics in 2021
4.2.3 Global Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Liver Failure Therapeutics Headquarters, Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Liver Failure Therapeutics Headquarters and Area Served
4.3.2 Global Liver Failure Therapeutics Companies Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Liver Failure Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Liver Failure Therapeutics Market Size by Company
4.5.1 Top Liver Failure Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Liver Failure Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Liver Failure Therapeutics Market Size by Region
5.1 Global Liver Failure Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Liver Failure Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Liver Failure Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Liver Failure Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Liver Failure Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Liver Failure Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Liver Failure Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Liver Failure Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Liver Failure Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Liver Failure Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Liver Failure Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Liver Failure Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Liver Failure Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Liver Failure Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Alfact Innovation
7.1.1 Alfact Innovation Company Details
7.1.2 Alfact Innovation Business Overview
7.1.3 Alfact Innovation Liver Failure Therapeutics Introduction
7.1.4 Alfact Innovation Revenue in Liver Failure Therapeutics Business (2017-2022)
7.1.5 Alfact Innovation Recent Development
7.2 BioLineRx Ltd
7.2.1 BioLineRx Ltd Company Details
7.2.2 BioLineRx Ltd Business Overview
7.2.3 BioLineRx Ltd Liver Failure Therapeutics Introduction
7.2.4 BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2017-2022)
7.2.5 BioLineRx Ltd Recent Development
7.3 Cell2B Advanced Therapeutics SA
7.3.1 Cell2B Advanced Therapeutics SA Company Details
7.3.2 Cell2B Advanced Therapeutics SA Business Overview
7.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Introduction
7.3.4 Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2017-2022)
7.3.5 Cell2B Advanced Therapeutics SA Recent Development
7.4 Conatus Pharmaceuticals Inc
7.4.1 Conatus Pharmaceuticals Inc Company Details
7.4.2 Conatus Pharmaceuticals Inc Business Overview
7.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Introduction
7.4.4 Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2017-2022)
7.4.5 Conatus Pharmaceuticals Inc Recent Development
7.5 Immune Pharmaceuticals Inc
7.5.1 Immune Pharmaceuticals Inc Company Details
7.5.2 Immune Pharmaceuticals Inc Business Overview
7.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Introduction
7.5.4 Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2017-2022)
7.5.5 Immune Pharmaceuticals Inc Recent Development
7.6 Mina Therapeutics Ltd
7.6.1 Mina Therapeutics Ltd Company Details
7.6.2 Mina Therapeutics Ltd Business Overview
7.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Introduction
7.6.4 Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2017-2022)
7.6.5 Mina Therapeutics Ltd Recent Development
7.7 Mylan NV
7.7.1 Mylan NV Company Details
7.7.2 Mylan NV Business Overview
7.7.3 Mylan NV Liver Failure Therapeutics Introduction
7.7.4 Mylan NV Revenue in Liver Failure Therapeutics Business (2017-2022)
7.7.5 Mylan NV Recent Development
7.8 Ocera Therapeutics Inc
7.8.1 Ocera Therapeutics Inc Company Details
7.8.2 Ocera Therapeutics Inc Business Overview
7.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Introduction
7.8.4 Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2017-2022)
7.8.5 Ocera Therapeutics Inc Recent Development
7.9 PledPharma AB
7.9.1 PledPharma AB Company Details
7.9.2 PledPharma AB Business Overview
7.9.3 PledPharma AB Liver Failure Therapeutics Introduction
7.9.4 PledPharma AB Revenue in Liver Failure Therapeutics Business (2017-2022)
7.9.5 PledPharma AB Recent Development
7.10 Promethera Biosciences SA
7.10.1 Promethera Biosciences SA Company Details
7.10.2 Promethera Biosciences SA Business Overview
7.10.3 Promethera Biosciences SA Liver Failure Therapeutics Introduction
7.10.4 Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2017-2022)
7.10.5 Promethera Biosciences SA Recent Development
7.11 Silence Therapeutics Plc
7.11.1 Silence Therapeutics Plc Company Details
7.11.2 Silence Therapeutics Plc Business Overview
7.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Introduction
7.11.4 Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2017-2022)
7.11.5 Silence Therapeutics Plc Recent Development
7.12 Unicyte AG
7.12.1 Unicyte AG Company Details
7.12.2 Unicyte AG Business Overview
7.12.3 Unicyte AG Liver Failure Therapeutics Introduction
7.12.4 Unicyte AG Revenue in Liver Failure Therapeutics Business (2017-2022)
7.12.5 Unicyte AG Recent Development
7.13 Ventria Bioscience
7.13.1 Ventria Bioscience Company Details
7.13.2 Ventria Bioscience Business Overview
7.13.3 Ventria Bioscience Liver Failure Therapeutics Introduction
7.13.4 Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2017-2022)
7.13.5 Ventria Bioscience Recent Development
7.14 Vital Therapies Inc
7.14.1 Vital Therapies Inc Company Details
7.14.2 Vital Therapies Inc Business Overview
7.14.3 Vital Therapies Inc Liver Failure Therapeutics Introduction
7.14.4 Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2017-2022)
7.14.5 Vital Therapies Inc Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Liver Failure Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Liver Failure Therapeutics Market Trends
Table 3. Liver Failure Therapeutics Market Drivers
Table 4. Liver Failure Therapeutics Market Challenges
Table 5. Liver Failure Therapeutics Market Restraints
Table 6. Global Liver Failure Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Liver Failure Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Liver Failure Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Liver Failure Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Liver Failure Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Liver Failure Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Liver Failure Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Liver Failure Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liver Failure Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Failure Therapeutics as of 2021)
Table 15. Top Players of Liver Failure Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Liver Failure Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Liver Failure Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Liver Failure Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Liver Failure Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Liver Failure Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Liver Failure Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Liver Failure Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Liver Failure Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Liver Failure Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Liver Failure Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Liver Failure Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Liver Failure Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Alfact Innovation Company Details
Table 31. Alfact Innovation Business Overview
Table 32. Alfact Innovation Liver Failure Therapeutics Product
Table 33. Alfact Innovation Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Alfact Innovation Recent Development
Table 35. BioLineRx Ltd Company Details
Table 36. BioLineRx Ltd Business Overview
Table 37. BioLineRx Ltd Liver Failure Therapeutics Product
Table 38. BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 39. BioLineRx Ltd Recent Development
Table 40. Cell2B Advanced Therapeutics SA Company Details
Table 41. Cell2B Advanced Therapeutics SA Business Overview
Table 42. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product
Table 43. Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Cell2B Advanced Therapeutics SA Recent Development
Table 45. Conatus Pharmaceuticals Inc Company Details
Table 46. Conatus Pharmaceuticals Inc Business Overview
Table 47. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product
Table 48. Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Conatus Pharmaceuticals Inc Recent Development
Table 50. Immune Pharmaceuticals Inc Company Details
Table 51. Immune Pharmaceuticals Inc Business Overview
Table 52. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product
Table 53. Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Immune Pharmaceuticals Inc Recent Development
Table 55. Mina Therapeutics Ltd Company Details
Table 56. Mina Therapeutics Ltd Business Overview
Table 57. Mina Therapeutics Ltd Liver Failure Therapeutics Product
Table 58. Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Mina Therapeutics Ltd Recent Development
Table 60. Mylan NV Company Details
Table 61. Mylan NV Business Overview
Table 62. Mylan NV Liver Failure Therapeutics Product
Table 63. Mylan NV Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Mylan NV Recent Development
Table 65. Ocera Therapeutics Inc Company Details
Table 66. Ocera Therapeutics Inc Business Overview
Table 67. Ocera Therapeutics Inc Liver Failure Therapeutics Product
Table 68. Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Ocera Therapeutics Inc Recent Development
Table 70. PledPharma AB Company Details
Table 71. PledPharma AB Business Overview
Table 72. PledPharma AB Liver Failure Therapeutics Product
Table 73. PledPharma AB Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 74. PledPharma AB Recent Development
Table 75. Promethera Biosciences SA Company Details
Table 76. Promethera Biosciences SA Business Overview
Table 77. Promethera Biosciences SA Liver Failure Therapeutics Product
Table 78. Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Promethera Biosciences SA Recent Development
Table 80. Silence Therapeutics Plc Company Details
Table 81. Silence Therapeutics Plc Business Overview
Table 82. Silence Therapeutics Plc Liver Failure Therapeutics Product
Table 83. Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Silence Therapeutics Plc Recent Development
Table 85. Unicyte AG Company Details
Table 86. Unicyte AG Business Overview
Table 87. Unicyte AG Liver Failure Therapeutics Product
Table 88. Unicyte AG Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 89. Unicyte AG Recent Development
Table 90. Ventria Bioscience Company Details
Table 91. Ventria Bioscience Business Overview
Table 92. Ventria Bioscience Liver Failure Therapeutics Product
Table 93. Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Ventria Bioscience Recent Development
Table 95. Vital Therapies Inc Company Details
Table 96. Vital Therapies Inc Business Overview
Table 97. Vital Therapies Inc Liver Failure Therapeutics Product
Table 98. Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2017-2022) & (US$ Million)
Table 99. Vital Therapies Inc Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Liver Failure Therapeutics Product Picture
Figure 2. Global Liver Failure Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Liver Failure Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Liver Failure Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Liver Failure Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Liver Failure Therapeutics Market Share in Global 2017-2028
Figure 7. Liver Failure Therapeutics Report Years Considered
Figure 8. Product Picture of Ornithine Phenylacetate
Figure 9. Product Picture of MTL-CEBPA
Figure 10. Product Picture of F-573
Figure 11. Product Picture of BL-1220
Figure 12. Product Picture of PP-100
Figure 13. Product Picture of Others
Figure 14. Global Liver Failure Therapeutics Market Share by Type in 2022 & 2028
Figure 15. Global Liver Failure Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 16. Global Liver Failure Therapeutics Market Share by Type (2017-2028)
Figure 17. United States Liver Failure Therapeutics Market Share by Type in 2022 & 2028
Figure 18. United States Liver Failure Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 19. United States Liver Failure Therapeutics Market Share by Type (2017-2028)
Figure 20. Product Picture of Clinic
Figure 21. Product Picture of Hospital
Figure 22. Product Picture of Others
Figure 23. Global Liver Failure Therapeutics Market Share by Application in 2022 & 2028
Figure 24. Global Liver Failure Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 25. Global Liver Failure Therapeutics Market Share by Application (2017-2028)
Figure 26. United States Liver Failure Therapeutics Market Share by Application in 2022 & 2028
Figure 27. United States Liver Failure Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 28. United States Liver Failure Therapeutics Market Share by Application (2017-2028)
Figure 29. North America Liver Failure Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. U.S. Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Canada Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Europe Liver Failure Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 33. Germany Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. France Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. U.K. Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Italy Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Russia Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Liver Failure Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 39. China Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Japan Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. South Korea Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. India Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Australia Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Taiwan Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Indonesia Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Thailand Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Malaysia Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Philippines Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Latin America Liver Failure Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Mexico Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Brazil Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Argentina Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Liver Failure Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 54. Turkey Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. U.A.E Liver Failure Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. Alfact Innovation Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 58. BioLineRx Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 59. Cell2B Advanced Therapeutics SA Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 60. Conatus Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 61. Immune Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 62. Mina Therapeutics Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 63. Mylan NV Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 64. Ocera Therapeutics Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 65. PledPharma AB Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 66. Promethera Biosciences SA Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 67. Silence Therapeutics Plc Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 68. Unicyte AG Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 69. Ventria Bioscience Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 70. Vital Therapies Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alfact Innovation BioLineRx Ltd Cell2B Advanced Therapeutics SA Conatus Pharmaceuticals Inc Immune Pharmaceuticals Inc Mina Therapeutics Ltd Mylan NV Ocera Therapeutics Inc PledPharma AB Promethera Biosciences SA Silence Therapeutics Plc Unicyte AG Ventria Bioscience Vital Therapies Inc